DataMeds AI (MEDS) financials · rev $23.3M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
DataMeds AI (MEDS) rev $23.3M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $23.3M | $18.1M |
| Cost of Revenue | $29.8M | $16.4M |
| Gross Profit | -$6.43M | $1.77M |
| Operating Income | -$93.7M | -$6.15M |
| Net Income | -$101.3M | -$6.86M |
| EPS (Diluted) | -$1.43 | -$0.15 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $30.5M | $57.3M |
| Current Assets | $2.82M | $15.2M |
| Cash & Equivalents | $42.6K | $1.03M |
| Inventory | $1.64M | $9.52M |
| PP&E | $229.4K | $388.2K |
| Total Liabilities | $42.9M | $50.6M |
| Current Liabilities | $29.8M | $38.0M |
| Short-term Debt | $10.9M | $11.9M |
| Long-term Debt | $12.6M | $11.5M |
| Total Debt | $23.5M† | $23.4M† |
| Shareholders' Equity | -$12.4M | $6.73M |
| Retained Earnings | -$111.0M | -$9.76M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$10.9M | -$1.22M |
| Investing Cash Flow | -$881.5K | $469.1K |
| Financing Cash Flow | $10.8M | $1.78M |
| Net Change in Cash | -$985.8K | $1.03M |
FAQ
What is MEDS P/E and revenue?
DataMeds AI (MEDS) rev $23.3M.
What is MEDS revenue?
DataMeds AI last cached revenue is $23.3M (FY2025).
Is MEDS profitable?
DataMeds AI last cached net income is -$101.3M (FY2025).
What are MEDS total assets?
DataMeds AI last cached total assets are $30.5M (FY2025).
What is MEDS free cash flow?
No cached cash-flow row for MEDS yet.
Not investment advice. Cached statements, not a live tape.